Insulin aspart, recombinant Subcutaneous and Prolensa ophthalmic
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Prolensa ophthalmic and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: bromfenac ophthalmic
Brand name: BromSite, Prolensa, Bromday, Xibrom
Synonyms: Prolensa (ophthalmic), Prolensa
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Proleukin
- Insulin aspart, recombinant Subcutaneous-Prolex D
- Insulin aspart, recombinant Subcutaneous-Prolia
- Insulin aspart, recombinant Subcutaneous-Prolida Patch
- Insulin aspart, recombinant Subcutaneous-Prolixin
- Insulin aspart, recombinant Subcutaneous-Prolixin Decanoate
- Prolensa ophthalmic-Insulin degludec
- Prolensa ophthalmic-Insulin Degludec (U-100) Prefilled Pens
- Prolensa ophthalmic-Insulin Degludec (U-100) Vials
- Prolensa ophthalmic-Insulin Degludec (U-200) Prefilled Pens
- Prolensa ophthalmic-Insulin degludec and liraglutide
- Prolensa ophthalmic-Insulin degludec and liraglutide Subcutaneous